Company overview
ABITEC Corporation specializes in manufacturing pharmaceutical-grade functional lipids, including CAPTEX medium chain triglycerides, CAPMUL mono- and diglycerides, and ACCONON pegylated esters, to enhance bioavailability of poorly soluble APIs. Their products meet USP/NF, EP compendial standards and are produced in FDA-audited cGMP facilities in the US. ABITEC also offers custom lipid synthesis for LNP therapeutics, contract manufacturing, and toll services for oleochemicals.
ABITEC Corporation is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include pharmaceutical lipids, lipid excipients, bioavailability enhancers, cgmp lipids, custom lipid synthesis.
Structured facts
- Website
- https://www.abiteccorp.com/en/
- Markets served
- United States & Americas
- Keywords
- pharmaceutical lipids, lipid excipients, bioavailability enhancers, cgmp lipids, custom lipid synthesis
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What pharmaceutical products does ABITEC manufacture?
- ABITEC manufactures lipid excipients like CAPTEX MCTs, CAPMUL mono/diglycerides, ACCONON pegylated esters, STEROTEX hydrogenated oils, and custom lipids for LNP therapeutics, all in cGMP facilities.
- What regulatory standards do ABITEC's pharma lipids meet?
- Products meet USP/NF, EP compendial requirements, cGMP, and IPEC guidelines, produced in FDA-audited, ISO-certified facilities in Janesville, WI and other US Midwest sites.
- Does ABITEC offer custom manufacturing or services for pharma?
- Yes, ABITEC provides custom lipid synthesis, contract and toll manufacturing for oleochemicals, blends, and new molecules, supporting research-grade to cGMP lipids globally.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
